Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in NERV — Minerva Neurosciences, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to NERV Full portfolio

Position in NERV

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$184,687
+$178,657 QoQ
Shares Held
33,277
+2118.5% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 58 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NERV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. NERV ranks #246 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in NERV

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $184,687 33,277
2025-12-31 $6,030 1,500
2021-06-30 $265,693 114,523
2021-03-31 $286,851 98,237
2020-12-31 $102,804 43,934
2020-09-30 $210,413 66,168
2020-06-30 $58,546 16,218
2020-03-31 $967,786 160,762